OpenAlex
PricingAboutJobs
Log inGet started
Work

Exenatide is Non-inferior to Insulin in Reducing HbA 1c : An Integrated Analysis of 1423 Patients with Type 2 Diabetes

HTML

Year: 2010
Type: article
Source: Postgraduate Medicine
DOI: 10.3810/pgm.2010.05.2149
Authors: Thomas Blevins, Jenny Han, Dawn Nicewarner, Steve Chen, Juliana H. A. Oliveira, Stephen Aronoff
Institutions: Texas Diabetes & Endocrinology, Eli Lilly (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, insulin, type 2 diabetes, glycemic control, HbA1c reduction, non-inferiority, weight loss, systolic blood pressure, hypoglycemia, GLP-1 receptor agonists, insulin therapy
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Amylin Pharmaceuticals, Merck
OpenAlex ID: W2118664840
FWCI: 3.03
Cites: 40
Cited by: 23
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security